time:2021-09-06 15:03:59
After inspection by 7 drug inspection institutions including Anhui Food and Drug Inspection and Research Institute, 18 batches of drugs, including cough peach powder, produced by 17 companies including Shaanxi Lijun Modern Chinese Medicine Co., Ltd., were not in compliance with the regulations. The relevant situation is now announced as follows:
1. After inspection by the Heilongjiang Provincial Drug Inspection and Research Center, a batch of compound bismuth aluminate tablets produced by Inner Mongolia Kaimeng Pharmaceutical Co., Ltd. did not meet the requirements, and the non-compliant items were weight differences.
After inspection by the China Food and Drug Control Institute, it was labeled as a batch of terazosin hydrochloride tablets produced by Wuhan Dongxin Pharmaceutical Technology Co., Ltd. which did not meet the requirements, and the items that did not meet the requirements were dissolution.
After inspection by Yunnan Food and Drug Administration, it was labeled as 1 batch of Chuanbei Qingfei syrup produced by Wuhan Xinrui Pharmaceutical Co., Ltd. that did not meet the requirements, and the items that did not meet the requirements were microbial limits.
After inspection by Anhui Food and Drug Inspection and Research Institute, it was labeled as Shaanxi Lijun Modern Chinese Medicine Co., Ltd. The 2 batches of cough peach blossom powder did not meet the requirements, and the items that did not meet the requirements were identified.
A batch of Atractylodes japonicus (fried atractylodes with bran) produced by the Hubei Provincial Institute of Drug Administration and Inspection, and labeled as Anhui Wogen Chinese Medicine Decoction Pieces Co., Ltd. does not meet the requirements. The non-compliant items include traits, identification, total ash and content determination.
According to the inspection of Gansu Provincial Institute of Drug Inspection, the 2 batches of Bupleurum (Bupleurum vinegar) produced by Henan Huaxia Medicinal Materials Co., Ltd. and Hunan Liucheng Chinese Medicine Decoction Pieces Co., Ltd. do not meet the requirements, and the items that do not meet the requirements are impurities; labeled as Hunan The two batches of Bupleurum spp. (Bupleurum vinegar) produced by Huaxia Xiangzhong Pharmaceutical Decoction Pieces Co., Ltd. and Yinhua Pharmaceutical Co., Ltd. of Zunyi City did not meet the requirements, and the items that did not meet the requirements were traits.
After being inspected by Chongqing Food and Drug Inspection and Testing Research Institute, it is labeled as Liaoning Fushuntang Pharmaceutical Co., Ltd., Anhui Huifeng National Pharmaceutical Co., Ltd., Hubei Shian Decoction Pieces Pharmaceutical Co., Ltd., Yangchun Bafang Chinese Medicine Decoction Pieces Co., Ltd., and Guangxi Dahong Pharmaceutical Co., Ltd. Co., Ltd., Sichuan Hongpu Pharmaceutical Co., Ltd., Guizhou Zhongheng Traditional Chinese Medicine Co., Ltd., Shaanxi Duoyao Traditional Chinese Medicine Decoction Pieces Co., Ltd. produced 8 batches of mulberry leaves that did not meet the requirements, and the items that did not meet the requirements were traits.
2. For the above-mentioned non-compliant drugs, the drug regulatory authority has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc., to investigate the reasons for non-compliance and effectively rectify them.
3. The State Drug Administration requires relevant provincial drug regulatory authorities to organize investigations into the illegal activities of the above-mentioned enterprises and units producing and selling counterfeit and inferior drugs in accordance with the Drug Administration Law of the People's Republic of China, and publicize the investigation results in accordance with regulations.
announce.
